Eli Lilly’s donanemab was expected to be approved this month, but the agency has decided to convene a panel of independent experts to evaluate the drug’s safety and efficacy.
Related Posts
![](https://static01.nyt.com/images/2023/12/08/multimedia/00dc-scotus-abortionpill-SWAP-mgtz/00dc-scotus-abortionpill-SWAP-mgtz-facebookJumbo.jpg)
Supreme Court Will Hear Challenge to Abortion Pill Access
The Supreme Court announced on Wednesday that it would decide on the availability of a commonly used abortion pill, the…
![](https://static01.nyt.com/images/2024/03/20/multimedia/20virus-future-promo-gtlc/20virus-future-promo-gtlc-facebookJumbo.jpg)
What’s Next for the Coronavirus?
Rat droppings from New York City. Poop from dog parks in Wisconsin. Human waste from a Missouri hospital. These are…
![](https://static01.nyt.com/images/2024/01/03/multimedia/00Gas-StationHeroin-01-zvlc/00Gas-StationHeroin-01-zvlc-facebookJumbo.jpg)
‘Gas-Station Heroin’ Sold as Dietary Supplement Alarms Health Officials
The young father headed across the parking lot to join the other parents meeting their children’s new preschool teachers. After…